Reuters logo
BRIEF-Spac I completes another step of reverse merger with CoGyn Pharmaceuticals
November 3, 2015 / 11:48 AM / 2 years ago

BRIEF-Spac I completes another step of reverse merger with CoGyn Pharmaceuticals

Nov 3 (Reuters) - Spac I SA :

* Completes another step of reverse merger with CoGyn Pharmaceuticals, Inc; transaction to be closed in few weeks

* Extraordinary shareholder meeting held on Nov. 2 approved name change to CoGyn Pharmaceuticals SA and chose new supervisory board

* New supervisory board plans to appoint Robert Cohen as new chairman of management board

* Plans to obtain 10 million zlotys funds in next 3 months to finance development, commercialization and licencing of CoGyn products

* To establish new units in Malta and Hong Kong

* To enter into Chinese market via its joint venture with Kangqi Pharmaceutical Co’s unit

* To apply to EU for subsidy for financing of its CoGyn products’ clinical trials Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below